J. Ardill

3.2k total citations
45 papers, 1.8k citations indexed

About

J. Ardill is a scholar working on Surgery, Epidemiology and Gastroenterology. According to data from OpenAlex, J. Ardill has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 18 papers in Epidemiology and 18 papers in Gastroenterology. Recurrent topics in J. Ardill's work include Neuroendocrine Tumor Research Advances (17 papers), Gastroesophageal reflux and treatments (16 papers) and Helicobacter pylori-related gastroenterology studies (16 papers). J. Ardill is often cited by papers focused on Neuroendocrine Tumor Research Advances (17 papers), Gastroesophageal reflux and treatments (16 papers) and Helicobacter pylori-related gastroenterology studies (16 papers). J. Ardill collaborates with scholars based in United Kingdom, Ireland and Sweden. J. Ardill's co-authors include K E McColl, Emad El‐Omar, Ian Penman, C A Dorrian, Kenneth E.L. McColl, K. D. Buchanan, A A Wirz, R S Chittajallu, W D Neithercut and David R. McCance and has published in prestigious journals such as The Lancet, Gut and British Journal of Cancer.

In The Last Decade

J. Ardill

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Ardill United Kingdom	22	811	662	604	581	389	45	1.8k
James R. Upp United States	18	422 0.5×	420 0.6×	68 0.1×	332 0.6×	126 0.3×	35	1.3k
G Lombardi Italy	20	576 0.7×	294 0.4×	121 0.2×	345 0.6×	27 0.1×	57	1.3k
L. Gullo Italy	22	1.2k 1.5×	310 0.5×	97 0.2×	669 1.2×	21 0.1×	71	1.5k
P. C. Ganguli United Kingdom	17	431 0.5×	231 0.3×	214 0.4×	87 0.1×	38 0.1×	31	1.0k
W. Niebel Germany	17	655 0.8×	70 0.1×	193 0.3×	186 0.3×	38 0.1×	69	1.1k
Claus Hovendal Denmark	17	555 0.7×	75 0.1×	265 0.4×	263 0.5×	21 0.1×	63	980
G. T. P. Saccone Australia	16	581 0.7×	110 0.2×	127 0.2×	153 0.3×	23 0.1×	64	918
R. B. Welbourn United Kingdom	16	399 0.5×	152 0.2×	133 0.2×	72 0.1×	60 0.2×	41	823
T. Holmin Sweden	17	558 0.7×	130 0.2×	47 0.1×	136 0.2×	93 0.2×	84	1.0k
Ryouichi Tomita Japan	20	802 1.0×	82 0.1×	415 0.7×	233 0.4×	17 0.0×	164	1.4k

Countries citing papers authored by J. Ardill

Since Specialization

Citations

This map shows the geographic impact of J. Ardill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ardill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ardill more than expected).

Fields of papers citing papers by J. Ardill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ardill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ardill. The network helps show where J. Ardill may publish in the future.

Co-authorship network of co-authors of J. Ardill

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ardill. A scholar is included among the top collaborators of J. Ardill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ardill. J. Ardill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ardill, J., et al.. (2015). Neuroendocrine tumours of the small bowel: interpretation of raised circulating chromogranin A, urinary 5 hydroxy indole acetic acid and circulating neurokinin A. QJM. 109(2). 111–115. 15 indexed citations

Yadegarfar, Ghasem, et al.. (2013). Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. British Journal of Cancer. 108(2). 301–310. 89 indexed citations

Ahmed, Alia, G. Turner, Barbara King, et al.. (2009). Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocrine Related Cancer. 16(3). 885–894. 215 indexed citations

Ardill, J., et al.. (2008). Vasoactive intestinal polypeptide secreting pancreatic tumour with hepatic metastases: long term survival after orthotopic liver transplantation. Irish Journal of Medical Science (1971 -). 179(3). 439–441. 2 indexed citations

Johnston, Brian T., David R. McCance, Ann McGinty, et al.. (2006). Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut. 55(11). 1586–1591. 97 indexed citations

Lindsay, John R., Aine McKillop, J. Ardill, et al.. (2005). Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes. Diabetic Medicine. 22(5). 654–657. 130 indexed citations

Turner, G. A., et al.. (2003). Clinical and biochemical prognostic indicators at diagnosis in 117 midgut carcinoid tumours.

Ardill, J., et al.. (2003). The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.. Endocrine Related Cancer. 10(4). 459–462. 71 indexed citations

Gillen, Derek, A A Wirz, W D Neithercut, J. Ardill, & K E McColl. (1999). Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut. 44(4). 468–475. 97 indexed citations

10.

El-Nujumi, A, Craig Williams, J. Ardill, Karin Oien, & Kenneth E.L. McColl. (1998). Eradicating Helicobacter pylori reduces hypergastrinaemia during long term omeprazole treatment. Gut. 42(2). 159–165. 22 indexed citations

11.

Hanna, Fahmy, J. Ardill, C.F. Johnston, et al.. (1997). Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. Journal of Endocrinology. 152(2). 275–281. 32 indexed citations

12.

El‐Omar, Emad, Sujoy Banerjee, A A Wirz, et al.. (1996). Marked rebound acid hypersecretion after treatment with ranitidine.. PubMed. 91(2). 355–9. 37 indexed citations

13.

McCallion, W A, et al.. (1995). Helicobacter pylori, hypergastrinaemia, and recurrent abdominal pain in children. Journal of Pediatric Surgery. 30(3). 427–429. 22 indexed citations

14.

Banerjee, Subhas, J. Ardill, A. D. Beattie, & K E McColl. (1995). Effect of omeprazole and feeding on plasma gastrin in patients with achlorhydria. Alimentary Pharmacology & Therapeutics. 9(5). 507–512. 6 indexed citations

15.

Mulholland, G. Keith, et al.. (1993). Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17.. Gut. 34(6). 757–761. 67 indexed citations

16.

Chittajallu, R S, W D Neithercut, J. Ardill, & Kenneth E.L. McColl. (1992). Helicobacter pylori-Related Hypergastrinaemia Is Not Due to Elevated Antral Surface pH Studies with Antral Alkalinisation. Scandinavian Journal of Gastroenterology. 27(3). 218–222. 16 indexed citations

17.

Fullarton, Grant, J. Ardill, & K E McColl. (1992). The effect of H₂‐blockade on plasma gastrin concentration in patients with an achlorhydric stomach. Alimentary Pharmacology & Therapeutics. 6(5). 557–563. 1 indexed citations

18.

Johnston, C.F., C. Shaw, J. Ardill, James M. Sloan, & K. D. Buchanan. (1988). Xenopsin immunoreactivity in antral G-cells may reside in the N-terminus of gastrin 17. Histochemistry and Cell Biology. 90(2). 161–164. 4 indexed citations

19.

Thomas, W E G, J. Ardill, & K.D. Buchanan. (1984). Suppression of somatostatin release by duodenogastric reflux in dogs.. Gut. 25(11). 1230–1233. 5 indexed citations

20.

Rooney, Patrick J., W C Dick, Robert C. Imrie, et al.. (1978). On the relationship between gastrin, gastric secretion, and adjuvant arthritis in rats.. Annals of the Rheumatic Diseases. 37(5). 432–435. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact